![](https://i0.wp.com/bioengineer.org/wp-content/uploads/2024/07/The-Texas-Heart-Institute-provides-BiVACOR®-Total-Artificial-Heart-Patient.jpeg?fit=700%2C394&ssl=1)
The Texas Heart Institute provides BiVACOR® Total Artificial Heart Patient update
Houston, Texas, July 26, 2024 – The Texas Heart Institute (THI), a globally renowned cardiovascular health center, and BiVACOR®, a leading clinical-stage medical device company, are pleased to provide an update on the condition of the first patient to …